1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. GLOBAL MICROFLUIDS MARKET BY COMPONENT
5.1. Introduction
5.2. Chips
5.3. Pumps
5.4. Sensors
5.5. Others
6. GLOBAL MICROFLUIDS MARKET BY SECTOR
6.1. Introduction
6.2. Industrial
6.3. Healthcare
7. GLOBAL MICROFLUIDS MARKET BY APPLICATION
7.1. Introduction
7.2. Point-of-care (POC) Diagnostics
7.3. Drug Delivery Systems
7.4. In-Vitro Diagnostics (IVD)
7.5. Pharmaceutical and Life Sciences Research
8. GLOBAL MICROFLUIDS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Illumina, Inc.
10.2. F. Hoffman-La Roche Ltd
10.3. PerkinElmer, Inc
10.4. Agilent Technologies, Inc
10.5. Bio-Rad Laboratories, Inc
10.6. Abbott
10.7. Standard BioTools
10.8. Agilent Technologies
10.9. Thermo Fisher Scientific
10.10. Danaher Corporation
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES